Gland Pharma Complete Financial Statements
GLAND • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for Gland Pharma (GLAND).
Downloads include all available records across all periods.
For market performance, see the
GLAND stock price today
.
Profitability Ratios
Net Profit Margin
11.71%
2025 data
EBITDA Margin
25.33%
2025 data
Operating Margin
21.00%
2025 data
Return on Assets
1.64%
2025 data
Return on Equity
2.01%
2025 data
Balance Sheet Ratios
Current Ratio
13.33
2025 data
Debt to Equity
1.23
2025 data
Equity Ratio
81.52%
2025 data
Asset Turnover
0.14
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+7.2%
Year-over-Year
Net Profit Growth
+12.2%
Year-over-Year
EBITDA Growth
+11.5%
Year-over-Year
Expense Growth
+5.8%
Year-over-Year
Assets Growth
+5.3%
Year-over-Year
Equity Growth
+4.9%
Year-over-Year
Liabilities Growth
+5.3%
Year-over-Year
Operating Cash Flow Growth
-8.2%
Year-over-Year
Investing Cash Flow Growth
+198.2%
Year-over-Year
Financing Cash Flow Growth
+45.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,571 | 1,469 | 1,563 | 1,466 | 1,580 | 1,453 | 1,443 | 1,427 | 824 | 1,246 | 1,583 | 1,110 | 1,168 | 931 | 1,000 | 1,132 | 935 | 1,216 | 1,109 | 852 | 681 | 916 | 895 |
| Expenses | 1,173 | 1,077 | 1,138 | 1,109 | 1,179 | 1,137 | 1,024 | 1,049 | 673 | 915 | 1,189 | 748 | 755 | 587 | 649 | 704 | 560 | 718 | 714 | 534 | 395 | 472 | 595 |
| EBITDA | 398 | 392 | 425 | 357 | 401 | 316 | 418 | 377 | 151 | 332 | 394 | 363 | 414 | 344 | 351 | 428 | 375 | 498 | 395 | 318 | 286 | 445 | 299 |
| Operating Profit Margin % | 21.00% | 24.00% | 24.00% | 21.00% | 23.00% | 19.00% | 26.00% | 24.00% | 14.00% | 24.00% | 23.00% | 28.00% | 32.00% | 32.00% | 31.00% | 35.00% | 37.00% | 38.00% | 33.00% | 36.00% | 38.00% | 47.00% | 31.00% |
| Depreciation | 106 | 96 | 101 | 94 | 93 | 92 | 96 | 81 | 38 | 65 | 105 | 37 | 31 | 35 | 38 | 26 | 25 | 25 | 28 | 25 | 24 | 24 | 25 |
| Interest | 8 | 7 | 12 | 6 | 10 | 6 | 23 | 6 | 2 | 5 | 5 | 2 | 2 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 284 | 288 | 313 | 257 | 298 | 218 | 299 | 290 | 111 | 261 | 283 | 324 | 381 | 309 | 311 | 401 | 349 | 472 | 366 | 293 | 262 | 420 | 273 |
| Tax | 100 | 102 | 97 | 93 | 106 | 75 | 95 | 96 | 33 | 67 | 91 | 83 | 95 | 79 | 79 | 99 | 89 | 121 | 93 | 74 | 67 | 106 | 69 |
| Net Profit | 184 | 187 | 216 | 164 | 192 | 144 | 205 | 194 | 79 | 194 | 192 | 241 | 286 | 229 | 232 | 302 | 260 | 351 | 273 | 219 | 195 | 314 | 204 |
| Earnings Per Share (₹) | 11.15 | 11.32 | 13.08 | 9.93 | 11.68 | 8.73 | 12.42 | 11.78 | 4.78 | 11.79 | 11.65 | 14.65 | 17.40 | 13.93 | 14.08 | 18.37 | 15.93 | 21.41 | 16.62 | 14.12 | 12.57 | 20.24 | 12.83 |
Related Pages for Gland Pharma
Additional stock information and data for GLAND
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 11,225 | 10,661 | 8,778 | 7,834 | 6,496 | 4,086 |
| Current Assets | 6,783 | 5,645 | 6,901 | 5,852 | 5,124 | 2,846 |
| Fixed Assets | 4,147 | 3,947 | 1,571 | 1,502 | 954 | 968 |
| Capital Work in Progress | 151 | 238 | 177 | 191 | 338 | 189 |
| Investments | 0 | 0 | 0 | 155 | 0 | 0 |
| Other Assets | 6,927 | 6,477 | 7,030 | 5,986 | 5,204 | 2,930 |
| LIABILITIES | ||||||
| Total Liabilities | 11,225 | 10,661 | 8,778 | 7,834 | 6,496 | 4,086 |
| Current Liabilities | 509 | 539 | 90 | 94 | 80 | 81 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 9,151 | 8,724 | 7,959 | 7,158 | 5,903 | 3,646 |
| Share Capital | 17 | 17 | 17 | 16 | 16 | 16 |
| Reserves & Surplus | 9,134 | 8,707 | 7,942 | 7,141 | 5,887 | 3,631 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | 915 | 997 | 364 | 791 | 605 | 701 |
| Investing Activities | 1,718 | -1,749 | 1,211 | -999 | -1,520 | -761 |
| Financing Activities | -434 | -799 | 15 | 35 | 1,239 | -7 |
| Net Cash Flow | 2,199 | -1,552 | 1,590 | -174 | 323 | -67 |